Thus, further studies are required to identify the developmental age showing the crucial alteration in the induction of the Btg2 and Adamsts1 genes as well as behavioral alterations associated with anxiety after treatment with the anxiogenic drug. This evidence concerns the gene BTG2 and Anxiety.